Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion type Assertion NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_head.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion description "[Subjects with hyperreactivity to epinephrine were more likely to exhibit hyperfunction in each major aspect of platelet activity, including adhesion (response to low-dose ristocetin; P < 0.001), activation (surface P-selectin expression and PAC-1 binding after stimulation; P <or= 0.003) and aggregation to other agonists [no agonist, adenosine diphosphate (ADP), arachidonic acid, collagen, collagen-related peptide and ristocetin; P <or= 0.025] and to applied shear stress (PFA-100 and cone-and-plate viscometer; P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_provenance.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion evidence source_evidence_literature NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_provenance.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion SIO_000772 16961612 NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_provenance.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion wasDerivedFrom befree-20150227 NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_provenance.
- NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_assertion wasGeneratedBy ECO_0000203 NP322581.RA3jh3XbnUkqdJIQ3hXonC1iy7WyV8dLNJ4PScpjhhRiI130_provenance.